Overjet vs VideaHealth: Comparing Dental AI Platforms
Overjet vs VideaHealth: a direct comparison of FDA clearances, DSO reach, clinical claims, and which dental AI fits your practice.
AI-assisted, human-governed and fact-checked — how we work.
Produced with AI assistance under human editorial governance and fact-checked against the cited sources. How we work.
| Attribute | Overjet Overjet | VideaHealth (Videa) VideaHealth / Videa |
|---|---|---|
| Price | Not publicly disclosed; contact sales for enterprise pricing. | Not publicly disclosed; contact sales for enterprise pricing. |
| Pros |
|
|
| Cons |
|
|
| Best for | Practices and DSOs where insurance pre-authorization workflows and payer integrations are a top priority, or those that need the most granular bone-level and PARL detection data. | Large group practices and DSOs already in the Henry Schein One / Dentrix ecosystem, or those joining networks where VideaHealth is the established standard. |
- Price
- Not publicly disclosed; contact sales for enterprise pricing.
- Pros
- Five separate FDA 510(k) clearances, each independently reviewed
- First-ever FDA-cleared periapical radiolucency segmentation tool
- Strong payer integrations with Guardian and Delta Dental
- Large-scale population data backing (340,000+ patients across 2,558 practices)
- Significant VC and ADA backing with $550M valuation
- Cons
- Pediatric caries coverage starts at age 4 vs. age 3 for VideaHealth
- Does not have VideaHealth's depth of DSO penetration at the very top tier
- No public pricing; enterprise sales process required
- Best for
- Practices and DSOs where insurance pre-authorization workflows and payer integrations are a top priority, or those that need the most granular bone-level and PARL detection data.
- Price
- Not publicly disclosed; contact sales for enterprise pricing.
- Pros
- 30+ algorithms under a single FDA clearance
- Pediatric detection starts at age 3
- 8 of top 10 DSOs; 90,000+ clinicians in North America per company figures
- Co-branded Dentrix Detect AI and Dentrix Ascend AI via Henry Schein One partnership
- Vendor-reported 43% reduction in missed cavities in clinical trial
- Cons
- Clinical outcome figures are vendor-reported and not yet independently replicated in peer-reviewed literature
- Rebranding to 'Videa' may create short-term confusion in vendor materials
- Smaller funding base than Overjet ($20M Series A vs. ~$133M total for Overjet)
- Less differentiated for practices outside the Dentrix/Henry Schein One ecosystem
- Best for
- Large group practices and DSOs already in the Henry Schein One / Dentrix ecosystem, or those joining networks where VideaHealth is the established standard.
Verdict: Overjet leads on regulatory depth and payer integrations; VideaHealth leads on DSO market penetration and PMS ecosystem reach — the right choice depends on your existing software stack and workflow priorities.
Choosing between Overjet and VideaHealth comes down to where your practice sits in the market: Overjet is the stronger fit for payer-facing workflows and DSOs that need granular bone-level and charting data; VideaHealth suits large group practices already embedded in the Henry Schein One / Dentrix ecosystem or networks where Aspen Dental and similar mega-DSOs have already standardized on it. Neither is a clear winner for every setting.
That said, this is a genuinely competitive space — and the differences matter more than the marketing suggests. Here’s what the sourced record actually shows.
Overjet vs VideaHealth: Company Origins and Funding
Both companies trace their roots to the same academic zip code. Overjet was founded by researchers from MIT and Harvard School of Dental Medicine; VideaHealth was similarly born out of Harvard and MIT research in 2018. For practices evaluating credibility, the shared lineage is a wash.
Where they diverge is scale of backing. Overjet raised a $53 million Series C — with the ADA among its investors — bringing total funding to roughly $133 million and a reported valuation of $550 million. VideaHealth closed a $20 million Series A led by Spark Capital, with Zetta Venture Partners and Pillar VC participating. Overjet’s balance sheet is considerably larger, which matters for long-term product investment and support depth.
FDA Clearances: Depth vs. Breadth
This is the sharpest technical distinction between the two platforms.
Overjet has earned five separate 510(k) clearances, each for a discrete capability. According to reporting by DrBicuspid, the first covered bone level measurement in bitewing and periapical radiographs for periodontal diagnosis. A second clearance followed for caries detection. The company then received a third clearance for periapical radiolucency (PARL) segmentation — described at the time as a first-of-its-kind clearance in dental AI. Charting Assist covers natural dental structures, restorations, implants, crowns, fillings, and endodontic treatment across bitewing, periapical, and panoramic radiographs for patients aged 5 and older. The fifth clearance, Overjet for Kids, covers pediatric caries in patients ages 4 and above across primary and permanent teeth.
VideaHealth took a different regulatory approach. Its Videa Dental Assist clearance encompasses more than 30 AI algorithms in a single submission — covering periapical radiolucencies, calculus, pediatric caries (ages 3 and older), and a range of other detections across all age groups. The pediatric age floor is one year lower than Overjet’s.
Neither approach is objectively superior. Overjet’s multi-clearance structure means each capability has been independently reviewed; VideaHealth’s single broader clearance gives it more algorithm coverage under one regulatory umbrella. For practices, the practical question is which detections they need day-to-day.
Clinical Evidence and Reported Outcomes
VideaHealth has published the more specific clinical numbers. Per vendor-reported figures, using the algorithm reduced missed cavities by 43% and cut erroneous caries detections by 15% on average. The company also reports an 80% improvement in true pediatric caries identification. These figures are reported by VideaHealth and have not been independently replicated in peer-reviewed literature as of this writing.
Overjet’s clinical story leans on population scale rather than a single trial metric. A Scientific Reports study built on Overjet’s FDA-cleared platform used data from more than 340,000 patients across 2,558 U.S. dental practices to develop an AI-derived oral scoring methodology — a meaningful demonstration of real-world deployment breadth.
Market Reach and Workflow Integrations
Overjet’s Payer Play
Overjet’s partnerships with Guardian and Delta Dental, two of the largest dental insurers in the country, are a significant differentiator. One DSO executive quoted in the research brief described a 2025 initiative using Overjet’s X-ray analysis to reduce wait times for pre-authorizations and claim approvals. If your practice or group spends meaningful time on insurance friction, that integration path is worth serious consideration.
Overjet also works with Dental Care Alliance and has been adopted across 750-plus practices through Aligned Dental Partners.
VideaHealth’s DSO Footprint
VideaHealth’s scale in the DSO market is hard to argue with. The company reports relationships with 8 of the 10 largest DSOs and over 90,000 clinicians in North America. The completed rollout across Aspen Dental’s 1,100-plus offices is one of the largest AI implementations in dentistry to date, per company figures. The Henry Schein One partnership — bringing co-branded Dentrix Detect AI and Dentrix Ascend AI powered by VideaHealth — extends that reach into tens of thousands of independent practices using those management systems.
For a practice already on Dentrix, the path of least resistance is clear. For a practice on a different PMS, that integration advantage disappears.
Pricing
Neither company publishes pricing. Both operate on enterprise or per-seat models negotiated through a sales process. Practices comparing the two should ask for a reference site in a similar-sized setting before signing anything. You can find a broader framework for evaluating these costs in our dental ai software buyer’s guide.
How They Stack Up Against the Broader AI Field
If you’re also evaluating Pearl, our overjet dental ai comparison covers that matchup in detail. VideaHealth’s position at the top of the DSO food chain does not mean it’s the default right answer for independent practices — particularly smaller ones that may find Dentrix integrations irrelevant or the onboarding overhead excessive.
The decision tree is fairly short: payer integrations are the priority → lean Overjet. Already in the Dentrix ecosystem or part of a DSO network where Videa is standard → Videa is the natural fit. Evaluating fresh with no existing integrations → request demos from both and ask specifically about PMS compatibility and support response times.
Frequently asked questions
How many FDA clearances does Overjet have compared to VideaHealth?
Overjet has received five separate FDA 510(k) clearances covering bone level measurement, caries detection, periapical radiolucency segmentation, dental charting, and pediatric caries. VideaHealth received a single FDA clearance for its Videa Dental Assist platform, which covers more than 30 algorithms including periapical radiolucencies, calculus, and pediatric caries for patients aged 3 and older.
Which dental AI platform is better for DSO use?
VideaHealth has broader DSO penetration, reporting relationships with 8 of the 10 largest DSOs and a completed rollout across Aspen Dental's 1,100-plus offices, per company figures. Overjet is also well represented in the DSO market through Dental Care Alliance and Aligned Dental Partners, and is particularly strong for organizations that need payer integrations with insurers like Guardian and Delta Dental.
Do Overjet and VideaHealth work with existing practice management software?
Both platforms integrate with major PMS and imaging software. VideaHealth has a notable partnership with Henry Schein One, powering co-branded Dentrix Detect AI and Dentrix Ascend AI. Overjet integrates across a range of platforms as well. Practices should verify specific compatibility with their current imaging and PMS setup before signing a contract.
Is VideaHealth the same as Videa?
Yes. VideaHealth has rebranded to 'Videa' as part of a broader platform expansion. The underlying technology and FDA clearances are the same; the brand name changed. Practices evaluating the product may see both names used interchangeably in industry materials.
Sources
- 1.Overjet receives FDA clearance for Dental Assist AI — DrBicuspid
- 2.Dental AI start-up Overjet receives second FDA clearance for software — Dental Tribune
- 3.Introducing Overjet for Kids: Dental AI That Parents Need — Dentistry Today
- 4.Overjet Announces FDA Approval for First-of-its-Kind PARL Segmentation Capability — Dentistry Today
The Digital Dentistry editorial team covers dental technology for practice owners, clinicians and dental labs. Our articles are produced with AI assistance under human editorial governance, fact-checked against cited primary sources, and updated as products and evidence change. See our editorial policy for how we work and how to flag a correction.